Varje dag samlar vi de senast publicerade vetenskapliga studierna om hampa, CBD och cannabis och sammanfattar kort vad var och en undersökte — på svenska och engelska. Alla länkar går till primärkällan (PubMed, Europe PMC eller ClinicalTrials.gov). Sammanfattningarna är neutrala beskrivningar av vad forskarna studerade, inte hälsopåståenden.
Simultaneous versus Sequential Cessation of Tobacco and Cannabis: Preferences of Young Adults Who Co-Use in France.
Drug Alcohol Rev · 2026 Sep · PubMed
Svenska: Co-use of tobacco and cannabis is common among young adults and is associated with higher dependence and quitting difficulties. Little is known about the preference for simultaneous or sequential dual cessation in this population.
Age and Cannabis Co-Use Are Associated with Differences in Experience and Perceived Benefits of Psilocybin: A Retrospective Study.
J Psychoactive Drugs · 2026 Sep 2 · PubMed
Svenska: As psychedelic use increases, understanding how demographic and behavioral factors influence the effects of psychedelics is essential for both research and public health.
Topical CBD Scar Healing Study
ClinicalTrials.gov (RECRUITING) · 2026-09-01 · ClinicalTrials.gov
Svenska: The purpose of this study is to find out what effects (good and bad) that cannabidiol (CBD) has on scar healing and appearance in patients who have undergone paramedian forehead flap reconstruction.
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
ClinicalTrials.gov (RECRUITING) · 2026-09-02 · ClinicalTrials.gov
Svenska: Cannabis is widely used worldwide and is associated with negative outcomes including cannabis use disorder (CanUD), psychosis, and cognitive impairment amongst others.
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
ClinicalTrials.gov (RECRUITING) · 2026-09-02 · ClinicalTrials.gov
Svenska: This study is a randomized, double-blind, placebo and active-controlled, multicenter trial conducted to evaluate whether PP-01 mitigates the withdrawal symptoms associated with discontinuing cannabis in participants with moderate to severe cannabis use disorder (CUD).